Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Vaccine
MODIFIED LIVE AND KILLED VIRUS
For veterinary use in cats only
Nobivac® Feline 1-HCP + FeLV vaccine is a combination vaccine that unites the benefits of Nobivac Feline 1-HCP and Nobivac FeLV in one vaccination.
Nobivac Feline 1-HCP vaccine is a modified live virus vaccine for the vaccination of healthy cats as an aid in the prevention of disease caused by feline rhinotracheitis, calici, and panleukopenia viruses.
Nobivac FeLV vaccine is recommended for the vaccination of healthy cats as an aid in the prevention of lymphoid tumors caused by, and diseases associated with, feline leukemia virus (FeLV) infection. Vaccination with this product prevents persistent viremia in cats exposed to virulent feline leukemia virus. The feline leukemia virus, subgroups A and B, are cultured in tissue culture cells. The virus has been chemically inactivated and combined with a proprietary adjuvant designed to enhance the immune response.
DOSAGE AND ADMINISTRATION:
Transfer contents of the Nobivac FeLV vial to the Nobivac Feline 1-HCP vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.
Prior to use, warm the Nobivac FeLV vaccine to room temperature and shake well.
Two doses are required for primary immunization.
Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 9 weeks of age or older.
Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination.
Revaccinate every two years with a single dose of Nobivac Feline 1-HCP + FeLV. Revaccination in the intervening years with Nobivac Feline 1-HCP is recommended.
Click here for our Vaccine Shipping Schedule.